Loading...
XSTO
ARCOMA
Market cap12mUSD
Jul 09, Last price  
8.46SEK
1D
-0.47%
1Q
1.44%
Jan 2017
124.40%
IPO
-27.51%
Name

Arcoma AB

Chart & Performance

D1W1MN
XSTO:ARCOMA chart
P/E
24.07
P/S
0.93
EPS
0.35
Div Yield, %
Shrs. gr., 5y
2.37%
Rev. gr., 5y
2.18%
Revenues
131m
-16.59%
147,661,334101,312,157130,434,000123,285,000102,081,00091,848,000119,470,000133,672,000117,417,000117,130,000125,046,000163,015,000156,807,000130,800,000
Net income
5m
-55.00%
-3,226,662-11,624,161914,000-6,449,000-11,646,000-9,820,000-1,586,0006,610,0001,365,000-7,473,0001,902,0002,564,00011,179,0005,030,000
CFO
19m
-0.66%
-10,267,844-11,822,783-828,000-4,948,000-4,666,000-8,910,00045,00011,100,0006,846,000-1,932,000-179,00019,160,00018,845,00018,720,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Arcoma AB is a global provider that designs, manufactures, and supplies cutting-edge radiology solutions. Their product line features advanced digital x-ray and radiography systems. These versatile systems are suitable for a wide array of radiographic applications and are utilized across various clinical environments, including general practice, musculoskeletal, thoracic, pediatric, and trauma/resuscitation units. The company distributes its products through a network of OEM partners. Arcoma AB was founded in 1990 and is headquartered in Växjö, Sweden.
IPO date
Nov 14, 2014
Employees
32
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT